275 related articles for article (PubMed ID: 15447725)
1. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
[TBL] [Abstract][Full Text] [Related]
2. Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient.
Williams C; Pontén F; Ahmadian A; Ren ZP; Ling G; Rollman O; Ljung A; Jaspers NG; Uhlén M; Lundeberg J; Pontén J
Cancer Res; 1998 Jun; 58(11):2449-55. PubMed ID: 9622088
[TBL] [Abstract][Full Text] [Related]
3. Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes.
Ren ZP; Hedrum A; Pontén F; Nistér M; Ahmadian A; Lundeberg J; Uhlén M; Pontén J
Oncogene; 1996 Feb; 12(4):765-73. PubMed ID: 8632898
[TBL] [Abstract][Full Text] [Related]
4. The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma.
Bäckvall H; Wolf O; Hermelin H; Weitzberg E; Pontén F
Br J Dermatol; 2004 Feb; 150(2):259-66. PubMed ID: 14996096
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
[TBL] [Abstract][Full Text] [Related]
6. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
7. Carcinogen-specific mutation pattern in the p53 tumour suppressor gene in UV radiation-induced basal cell carcinoma.
Weihrauch M; Bader M; Lehnert G; Wittekind C; Tannapfel A; Wrbitzky R
Int Arch Occup Environ Health; 2002 Apr; 75(4):272-6. PubMed ID: 11981662
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology in basal cell cancer with p53 as a genetic marker.
Pontén F; Berg C; Ahmadian A; Ren ZP; Nistér M; Lundeberg J; Uhlén M; Pontén J
Oncogene; 1997 Aug; 15(9):1059-67. PubMed ID: 9285560
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.
Sato M; Nishigori C; Zghal M; Yagi T; Takebe H
Cancer Res; 1993 Jul; 53(13):2944-6. PubMed ID: 8319200
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations in basal cell carcinomas arising in routine users of sunscreens.
Rosenstein BS; Phelps RG; Weinstock MA; Bernstein JL; Gordon ML; Rudikoff D; Kantor I; Shelton R; Lebwohl MG
Photochem Photobiol; 1999 Nov; 70(5):798-806. PubMed ID: 10568172
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin.
Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270
[TBL] [Abstract][Full Text] [Related]
13. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
14. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin.
Ren ZP; Ahmadian A; Pontén F; Nistér M; Berg C; Lundeberg J; Uhlén M; Pontén J
Am J Pathol; 1997 May; 150(5):1791-803. PubMed ID: 9137102
[TBL] [Abstract][Full Text] [Related]
15. Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinoma.
Ahmadian A; Ren ZP; Williams C; Pontén F; Odeberg J; Pontén J; Uhlén M; Lundeberg J
Oncogene; 1998 Oct; 17(14):1837-43. PubMed ID: 9778050
[TBL] [Abstract][Full Text] [Related]
16. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
Chen B; Campos EI; Crawford R; Martinka M; Li G
Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p53 protein in basal cell carcinomas of human skin.
Shea CR; McNutt NS; Volkenandt M; Lugo J; Prioleau PG; Albino AP
Am J Pathol; 1992 Jul; 141(1):25-9. PubMed ID: 1632467
[TBL] [Abstract][Full Text] [Related]
18. Sunburn and p53 in the onset of skin cancer.
Ziegler A; Jonason AS; Leffell DJ; Simon JA; Sharma HW; Kimmelman J; Remington L; Jacks T; Brash DE
Nature; 1994 Dec 22-29; 372(6508):773-6. PubMed ID: 7997263
[TBL] [Abstract][Full Text] [Related]
19. UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin.
Luo JL; Tong WM; Yoon JH; Hergenhahn M; Koomagi R; Yang Q; Galendo D; Pfeifer GP; Wang ZQ; Hollstein M
Cancer Res; 2001 Nov; 61(22):8158-63. PubMed ID: 11719445
[TBL] [Abstract][Full Text] [Related]
20. TP53 mutations in human skin cancers.
Giglia-Mari G; Sarasin A
Hum Mutat; 2003 Mar; 21(3):217-28. PubMed ID: 12619107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
